Biognosys is a leading contract research organization (CRO) specializing in proteomics services for early-stage R&D through clinical trial biomarker monitoring. Partnering with the most innovative biotech and pharmaceutical companies worldwide, Biognosys utilizes unique, patented technologies and high-resolution mass spectrometry to quantify thousands of proteins with unmatched precision, depth, and throughput. With laboratories near Zurich, Switzerland and Boston, Massachusetts, Biognosys combines scientific expertise and next-generation proteomics to accelerate drug discovery and development, and supports translational and preclinical research, and clinical trials for precision medicine. Learn more at www.biognosys.com
Biodesix
Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. To deliver on our mission to transform patient care and improve outcomes through personalized diagnostics, we provide advanced diagnostic tests and custom diagnostic development services. | Biodesix is a leading diagnostic solutions and services company with a focus in lung disease. Biodesix offers five Medicare-covered tests for patients with lung diseases. The blood-based Nodify Lung® Nodule Risk Assessment testing portfolio evaluates the risk of malignancy in incidental pulmonary nodules, enabling physicians to better triage patients to the most appropriate course of action. The blood based IQLung™ portfolio supports treatment decisions across all stages of lung cancer with results in an average of two to three business days, expediting the time to treatment. For more information, www.biodesix.com.
BioDot
BioDot has provided low-volume dispensing solutions to the Diagnostics, Drug Discovery, and Life Sciences fields since 1994. Our systems deliver accurate microliter-to-picoliter dispensing, enabling laboratories to integrate automation and miniaturization into workflows while maintaining sample integrity and experimental reproducibility. Visit our booth to see our new dynamic platform in operation and explore its applications in modern laboratory workflows.
BioDuro
BioDuro, an Advent International portfolio company is a trusted, leading contract research development, and manufacturing organization (CRDMO) for 30 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. The company is based in the US with operations in China, totaling 2,000+ scientists and 7 global sites across 6 cities. Core expertise includes small and large molecule discovery, development and scale-up, support for IND submission, and unique technology platforms such as bioavailability enhancement of insoluble compounds. The one-stop-shop operation helps biotech and pharma partners across the globe to significantly accelerate discovery and de-risk development to create higher value outcomes. We adhere to one global highest standard of compliance and business operation code. Science-driven, customer-oriented, flexible, people-focused culture enables us to provide top-tier integrated, fast and flexible tailored services to our customers to meet their unique needs and accelerate our development timeline. For more information about BioDuro, please visit our website at www.bioduro-sundia.com | BioDuro, an Advent portfolio company, is a CRDMO with a 30-year proven track record. Headquartered in Irvine, California, BioDuro employs more than 2,000 scientists with deep expertise in small- and large-molecule discovery, development, and manufacturing. We provide fully integrated drug discovery services spanning chemistry, biology, and pharmacokinetics (DMPK), along with comprehensive IND-enabling capabilities, including both drug substance and drug product development.
Biocompare
Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.
Bio-Techne Spatial
Bio-Techne Spatial, a leader in applied spatial biology solutions, empowers scientists and clinicians around the world to push the boundaries of science and medicine. Bio-Techne Spatial is built on technological excellence to deliver targeted, scalable spatial biology solutions and accelerate breakthroughs that improve patient lives. Powered by the gold-standard RNAscope™ technology and the end-to-end COMET™ Suite, the comprehensive ecosystem of best-in-class reagents, instruments, and analysis software enables versatile and reliable workflows for RNA, protein, and multiomic detection with unmatched analytical performance.
Bio-Rad Laboratories
With over 60 years of expertise in genomics, proteomics, and cell biology, depend on Bio-Rad for tools and technologies to enable cancer research. Bio-Rad provides instrumentation and reagents for Droplet Digital PCR, Real-Time PCR, CTC Capture and Recovery, Flow Cytometry, and Western Blotting. | Depend on Bio-Rad Laboratories for a wide range of solutions for life science research and clinical diagnostics customers. As a global leader in genomics for over 70 years, Bio-Rad offers a comprehensive range of reagents, consumables, software, and instruments for Droplet Digital PCR, Real-Time PCR, Next-Generation Sequencing solutions. and Single-Cell Solutions.
BillionToOne – NorthStar
We’re a precision diagnostics company that quantifies biology to create powerful molecular diagnostics. We work to improve disease detection by counting molecules with our proprietary molecular counting platform. We place patients at the forefront of everything we do. We are currently applying our proprietary technology to non-invasive prenatal screening and liquid biopsy. The Northstar Select™ provides a prioritized list of mutations that are present in the tumor. The types of mutations detected include deletions, insertions, and point-mutations. At the same time, it helps rule-in / rule-out relationship of mutations to drugs and provides an accurate read on the covered genes. The Northstar Response™ provides longitudinal determination of cancer burden via methylation assessment.
Beckman Coulter Life Sciences
From the Human Genome Project to today’s quest for precision medicine, we’ve long invested in providing genomic solutions that reduce complexity and improve productivity. These solutions come in the form of empowering reagents and enlightening automation, all of which will be on display in the Danaher booth 4217 at the AACR annual meeting 2026. We look forward to seeing you in San Diego and showing you how we harness the power of SPRI technology in our genomic reagents, enabling them to produce high-quality nucleic acid samples. These samples support a wide range of applications, including qPCR, ddPCR, Sanger sequencing, next-generation sequencing (NGS) and microarrays. | With a legacy dating to 1935, Beckman Coulter continues our mission to help a diverse variety of experts discover answers to some of life’s most important questions. The BioLector XT is a high-throughput microbioreactor enabling real-time evaluation of biomass, fluorescence, pH, dissolved oxygen and other key cultivation parameters to enhance your microbial strain screening and process optimization. De-risk your scale-up with BioLector XT. | Beckman Coulter serves a diverse range of customers in the industrial market in areas such as aerospace, automobile, agriculture, chemicals, construction, fuels, and electronics, to name a few. The company is a key supplier to quality control and standard operating processes with products in air and liquid particle counting as well as laser diffraction for particle size distribution. Visit Beckman Coulter’s Web site for more details.
AURIGENE PHARMACEUTICAL SERVICES LIMITED
Aurigene Pharmaceutical Services Limited is a leading contract research, development, and manufacturing organization (CRO/CDMO) and a long-term partner providing end-to-end solutions thereby accelerating innovation. With a strong legacy of services in discovery chemistry, discovery biology, development and manufacturing we are ideally positioned to serve global pharma and specialty companies worldwide by providing truly integrated services. We handle both small molecule and large-molecule services across various complex technology platforms and niche technologies. We have access to FDA-inspected dedicated R and D centers in India and cGMP sites across India, UK and Mexico. Beyond science, our operations are rooted in the fundamental principles of compliance, information security, quality and sustainability. | Aurigene Pharmaceutical Services is leading contract research, development, and manufacturing organization (CDMO). Built on the legacy of accelerating innovation and backed by a vast experience in drug discovery and development our mission is to relentlessly work for the success of our clients and to build long term relationships through a holistic approach to accelerate the journey of a molecule from laboratory to market. By providing access to our resources, knowledge and experience, we create success for our clients and ultimately patients. We offer integrated and standalone services for medicinal chemistry, biology, preclinical services, DMPK studies, development and manufacturing for clinical phase I-III programs, regulatory submission batches and commercial manufacturing. A differentiating factor is the integrated API and formulations service that spans from key starting material, advanced intermediates, APIs to finished products such as oral solids, sterile products, nasal solutions etc. Our development services in India are complemented by cGMP commercial manufacturing facilities in the UK, Mexico, USA and India.